Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of HN2011002992ApublicationCriticalpatent/HN2011002992A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Steroid Compounds
(AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN COMPUESTO DE LA FORMULA (i), UN METODO PARA LA ELEBORACION DE LOS COMPUESTOS DE LA INVENCION, Y SUS USOS TERAPEUTICOS. LA PRESENTE INVENCION PRPORCIONA ADEMAS UNA COMBINACION DE AGENTES FARMACOLOGICAMENTE ACTIVOS Y UNA COMPOSICION FARMACEUTICA.THIS INVENTION PROVIDES A COMPOUND OF FORMULA (i), A METHOD FOR THE COMPLETION OF THE COMPOUNDS OF THE INVENTION, AND ITS THERAPEUTIC USES. THIS INVENTION ALSO PROVIDES A COMBINATION OF PHARMACOLOGICALLY ACTIVE AGENTS AND A PHARMACEUTICAL COMPOSITION.
HN2011002992A2009-05-152011-11-11
ARIL-PYRIDINS AS INHIBITORS OF SINTASA DE ALDOSTERONA
HN2011002992A
(en)